DE60231892D1 - Verwendung von lh für die kontrollierte ovarielle hyperstimulation - Google Patents

Verwendung von lh für die kontrollierte ovarielle hyperstimulation

Info

Publication number
DE60231892D1
DE60231892D1 DE60231892T DE60231892T DE60231892D1 DE 60231892 D1 DE60231892 D1 DE 60231892D1 DE 60231892 T DE60231892 T DE 60231892T DE 60231892 T DE60231892 T DE 60231892T DE 60231892 D1 DE60231892 D1 DE 60231892D1
Authority
DE
Germany
Prior art keywords
ovarian hyperstimulation
controlled ovarian
controlled
hyperstimulation
ovarian
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60231892T
Other languages
English (en)
Inventor
Stephen Hillier
Colin Michael Sero Howles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SA
Original Assignee
Laboratoires Serono SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8182260&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60231892(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratoires Serono SA filed Critical Laboratoires Serono SA
Application granted granted Critical
Publication of DE60231892D1 publication Critical patent/DE60231892D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE60231892T 2001-09-12 2002-09-12 Verwendung von lh für die kontrollierte ovarielle hyperstimulation Expired - Lifetime DE60231892D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01307755 2001-09-12
PCT/GB2002/004147 WO2003022301A2 (en) 2001-09-12 2002-09-12 Use of lh in controlled ovarian hyperstimulation

Publications (1)

Publication Number Publication Date
DE60231892D1 true DE60231892D1 (de) 2009-05-20

Family

ID=8182260

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60231892T Expired - Lifetime DE60231892D1 (de) 2001-09-12 2002-09-12 Verwendung von lh für die kontrollierte ovarielle hyperstimulation

Country Status (28)

Country Link
US (1) US7341989B2 (de)
EP (1) EP1434600B1 (de)
JP (1) JP2005504072A (de)
KR (1) KR20040032953A (de)
CN (1) CN1302806C (de)
AR (1) AR036591A1 (de)
AT (1) ATE427755T1 (de)
AU (1) AU2002331939B2 (de)
BR (1) BR0212502A (de)
CA (1) CA2457067A1 (de)
CY (1) CY1110487T1 (de)
DE (1) DE60231892D1 (de)
DK (1) DK1434600T3 (de)
EA (1) EA009210B1 (de)
ES (1) ES2322136T3 (de)
HK (1) HK1067866A1 (de)
HR (1) HRP20040070A2 (de)
IL (1) IL160781A0 (de)
ME (1) MEP38808A (de)
MX (1) MXPA04002125A (de)
NO (1) NO327154B1 (de)
PL (1) PL205472B1 (de)
PT (1) PT1434600E (de)
RS (1) RS51505B (de)
SI (1) SI1434600T1 (de)
UA (1) UA78970C2 (de)
WO (1) WO2003022301A2 (de)
ZA (1) ZA200401008B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1684737A (zh) * 2002-06-07 2005-10-19 阿雷斯贸易股份有限公司 控制性超排卵方法及该方法使用的药物试剂盒
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
CN102296047B (zh) * 2011-08-13 2013-03-13 新疆农垦科学院 利用羔羊超排卵母细胞生产体外胚胎的方法
US20150272622A1 (en) 2011-12-22 2015-10-01 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
US9216037B2 (en) 2013-06-21 2015-12-22 Previvo Genetics, Llc Uterine lavage for embryo retrieval
US9282995B2 (en) * 2011-12-22 2016-03-15 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
EP2968391A1 (de) 2013-03-13 2016-01-20 Moderna Therapeutics, Inc. Langlebige polynukleotidmoleküle
RU2629871C1 (ru) * 2016-03-22 2017-09-04 Сергей Михайлович Юдин Препарат для стимуляции фолликулогенеза и способ его применения
IT202000022015A1 (it) * 2020-09-18 2022-03-18 Marca Antonio La Nuovo uso dell'ormone luteinizzante

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4589402A (en) 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
CA2372714A1 (en) * 1999-05-07 2000-11-16 Stephen Franks The use of luteinizing hormone in the induction of pauci-or unifolliculogenesis

Also Published As

Publication number Publication date
HK1067866A1 (en) 2005-04-22
CY1110487T1 (el) 2015-04-29
UA78970C2 (uk) 2007-05-10
AR036591A1 (es) 2004-09-22
PL205472B1 (pl) 2010-04-30
IL160781A0 (en) 2004-08-31
RS51505B (sr) 2011-06-30
WO2003022301A3 (en) 2003-04-17
AU2002331939B2 (en) 2007-10-25
CN1302806C (zh) 2007-03-07
PL367343A1 (en) 2005-02-21
BR0212502A (pt) 2004-08-24
EA009210B1 (ru) 2007-12-28
US7341989B2 (en) 2008-03-11
KR20040032953A (ko) 2004-04-17
ZA200401008B (en) 2005-08-31
MXPA04002125A (es) 2004-07-08
JP2005504072A (ja) 2005-02-10
NO20040990L (no) 2004-03-08
ES2322136T3 (es) 2009-06-17
HRP20040070A2 (en) 2004-10-31
DK1434600T3 (da) 2009-05-25
EP1434600A2 (de) 2004-07-07
CA2457067A1 (en) 2003-03-20
ATE427755T1 (de) 2009-04-15
CN1553809A (zh) 2004-12-08
US20050049199A1 (en) 2005-03-03
NO327154B1 (no) 2009-05-04
YU21204A (sh) 2006-08-17
PT1434600E (pt) 2009-04-28
MEP38808A (en) 2011-02-10
WO2003022301A2 (en) 2003-03-20
EA200400428A1 (ru) 2004-08-26
SI1434600T1 (sl) 2009-06-30
EP1434600B1 (de) 2009-04-08

Similar Documents

Publication Publication Date Title
DE60227932D1 (de) Spannungsregler
DE50212455D1 (de) Verwendung von Dimerdiolen
DE60202401D1 (de) Eingangsschaltung für Sendeempfänger
DE60228580D1 (de) Mechanismus für die programmierbare änderung der speicherzuordnungsgranularität
ITMI20010008A0 (it) Additivi per fluoropolieterei per applicazioni elettromagnetiche
HK1067867A1 (en) Use of hcg in controlled ovarian hyperstimulation
DE50209426D1 (de) Verarbeitung von Acrylat-Hotmelts mittels reaktiver Extrusion
DE02784674T1 (de) Quantifizierung von polypeptiden
DE60220654D1 (de) Musterungsmethode
BR0209857B1 (pt) ferramenta corrediÇa de suspensor de revestimento e processo
DE60231892D1 (de) Verwendung von lh für die kontrollierte ovarielle hyperstimulation
DE502004011575D1 (de) Verwendung von Dioldimerfettsäureestern
DE502004005362D1 (de) Auslegung von werkzeugen und prozessen für die umformtechnik
DK1353923T3 (da) Forbedret fremgangsmåde til syntese af carbapenem
ATA12182002A (de) Schaltwandler
DE60223457D1 (de) Spannungsreglerssteuerschaltung
DE50204295D1 (de) Variabler riemenhochtrieb für nebenaggregate
DE60203608D1 (de) Metallblöcke für bearbeitungsverwendungen
IS6888A (is) Aðferð við meðferð sykursýki af gerð I
DE60232935D1 (de) Herstellungsverfahren von Druckeinheiten
DE502004002460D1 (de) Verwendung von copolymerisaten als hilfsmittel für die lederherstellung
ITMI20011553A0 (it) Processo per la sintesi di ammoniaca
DE50205392D1 (de) Drahtgarnitur für Karde
ATE325120T1 (de) Neue verwendung substituierter aminomethylchromane
FR2823975B1 (fr) Nouvelle utilisation de pyridoindolone

Legal Events

Date Code Title Description
8363 Opposition against the patent